Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Operating activities
Net loss from operations	$ (1,136,665)	$ (45,156)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization and other non-cash items	482,042	903,420
Deferred income tax benefit	(56,000)	(211,000)
Stock-based compensation	83,865	728,993
Deferred income	(23,920)	(8,583)
Deferred lease liability	46	4,631
Changes in operating assets and liabilities:
Accounts receivable	99,259	402,154
Inventories	(116,874)	(1,848,313)
Prepaid expenses and other assets	189,522	66,261
Accounts payable and accrued expenses	377,394	168,333
Net cash (used in)/provided by operating activities	(101,331)	160,740
Investing activities
Acquisition of property, plant and equipment	(167,548)	(328,285)
Additional patents	(155,175)	(46,204)
Net cash used in investing activities	(322,723)	(374,489)
Financing activities
Proceeds from the sale of common stock	4,000,000
Proceeds from exercise of stock options	140,847	147,755
Net cash provided by financing activities	4,140,847	147,755
Net increase / (decrease) in cash and cash equivalents	3,716,793	(65,994)
Cash and cash equivalents at beginning of period	9,049,327	9,623,749
Cash and cash equivalents at end of period	12,766,120	9,557,755
Supplemental disclosure of cash flow information:
Cash paid for income taxes	2,053	131,325
Capitalization of consigned product	$ 953,258	$ 741,497